##  [Novartis receives FDA approval for Arcapta™ Neohaler™, a novel once-daily bronchodilator for chronic obstructive pulmonary disease](/us-en/news/media-releases/novartis-receives-fda-approval-arcaptatm-neohalertm-novel-once-daily-bronchodilator-chronic-obstructive-pulmonary-disease-0 "Novartis receives FDA approval for Arcapta™ Neohaler™, a novel once-daily bronchodilator for chronic obstructive pulmonary disease") 

  Jul 01, 2011